Intraoral application of atropine sulfate ophthalmic solution for clozapine-induced sialorrhea.
Sharma
Ashish
A
Ramaswamy
Sriram
S
Dahl
Elizabeth
E
Dewan
Vijay
V
D000284:Administration, Oral; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001285:Atropine / Q000008:administration & dosage / Q000627:therapeutic use*; D003024:Clozapine / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D018727:Muscarinic Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D009883:Ophthalmic Solutions; D012563:Schizophrenia, Paranoid / Q000188:drug therapy; D012798:Sialorrhea / Q000139:chemically induced / Q000188:drug therapy*
D014150:Antipsychotic Agents; D018727:Muscarinic Antagonists; D009883:Ophthalmic Solutions; D001285:Atropine; D003024:Clozapine